# Getinge sells biosurgery business to HJ Capital 1

Getinge's Atrium Medical has agreed to sell its biosurgery business, which makes soft tissue reinforcement devices, to HJ Capital 1, parent of SeCQure Surgical. The deal covers all assets and liabilities except mesh liability claims, with no material financial impact.

- Type: Acquisition
- Announced: 2018-10-18
- Where: United States
- Status: announced
- Products: soft tissue reinforcement devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Getinge](https://endata.com/companies/34980.md) (partner)
- [HJ Capital 1](https://endata.com/companies/34981.md) (acquirer)
- [SeCQure Surgical](https://endata.com/companies/34982.md) (partner)

## Sources

- [massdevice.com](https://www.massdevice.com/getinges-atrium-medical-deals-biosurg-biz-to-secqure-surgical-parent/), 2018-10-18: "Today Getinge said it agreed to sell the business, which at $14.2 million in 2017 sales (SEK 128 million) is a relatively small segment, to SeCQure parent HJ Capital 1."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.